抑制NADPH氧化酶4是一种对脊髓肌肉缩的补充治疗策略
Mirella El Khoury1,2, Olivier Biondi1, Gaelle Bruneteau3,4
1Faculty of Basic and Biomedical Sciences, University Paris Cité & Inserm UMR_S1124, Paris, France.
Frontiers in cellular neuroscience
|October 2, 2023
概括
用GKT137831/Setanaxib抑制NADPH氧化酶4 (NOX4) 保护脊髓肌缩 (SMA) 小鼠的运动神经元. 这种神经保护作用为SMA患者提供了潜在的补充疗法.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脊髓肌肉缩 (SMA) 是一种致命的神经退行性疾病,由运动神经元 (SMN) 的生存耗尽引起,导致运动神经元 (MN) 损失.
- 目前增加SMN的疗法是有效的,但并非适用于所有患者,因此需要组合策略.
研究的目的:
- 研究NADPH氧化酶4 (NOX4) 在SMA引起的MN死亡中的作用.
- 评估SMA中调节NOX4活性的治疗潜力.
主要方法:
- 在SMA小鼠脊髓中分析了氧化应激和NOX4表达.
- 通过内注射NOX4抑制剂GKT137831/Setanaxib来评估MN生存和运动行为.
- 测试了GKT137831/Setanaxib与SMN上调治疗的协同作用.
主要成果:
- 在SMA小鼠中,NOX4过度表达;它的抑制由GKT137831/Setanaxib保护MNs.
- 在SMA小鼠中,GKT137831/Setanaxib治疗显著增加了寿命,改善了运动行为.
- 药物抑制激活了AKT/CREB通路,增加了SMN表达,并与现有疗法展现了协同作用.
结论:
- 通过GKT137831/Setanaxib对NOX4的药理抑制表明在SMA中具有显著的神经保护作用.
- 抑制NOX4代表了脊柱肌肉缩的一个有希望的补充治疗策略.
关键词:
GKT137831 一个国家在NADPH氧化酶4中.塞塔纳克西布 (Setanaxib) 是一种药物.脊柱肌肉缩 脊柱肌肉缩 脊柱肌肉缩神经退行性疾病的神经退行性疾病氧化应激是一种氧化应激.严重类型的SMA类小鼠更多相关视频
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
60.9K
07:33Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors
Published on: May 1, 2019
11.4K
相关概念视频
01:30The Electron Transport Chain
16.9K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.9K
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K